Effect of preventive treatment for tuberculosis in adults infected with HIV: systematic review of randomised placebo controlled trials
about
Treatment of latent tuberculosis infection in HIV infected personsTreatment of latent tuberculosis infection in HIV infected personsContribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infectionIsoniazid Prophylactic Therapy for the Prevention of Tuberculosis in HIV Infected Adults: A Systematic Review and Meta-Analysis of Randomized TrialsDiagnosis & treatment of tuberculosis in HIV co-infected patients.A re-examination of the potential impact of preventive therapy on the public health problem of tuberculosis in contemporary sub-Saharan Africa.Impact of HIV infection on tuberculosisDrugs for preventing tuberculosis in HIV infected persons.Predictors of adherence to isoniazid preventive therapy among HIV positive adults in Addis Ababa, EthiopiaIssues facing TB control (6). Tuberculosis control in sub-Saharan Africa in the face of HIV and AIDS.Timing of antiretroviral therapy for HIV in the setting of TB treatment.Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.The effect of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected clients under pre-ART care, Jimma, Ethiopia: a retrospective cohort study.Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial.Isoniazid preventive therapy and risk for resistant tuberculosis.HIV-associated tuberculosis and cryptococcosis in resource-limited settings.Integrating tuberculosis and HIV services for people living with HIV: costs of the Zambian ProTEST Initiative.Tuberculosis and HIV co-infection: screening and treatment strategies.Opportunistic infections associated with HIV infection in Africa.Interpreting meta-analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individualsRecommendations for screening and prevention of tuberculosis in patients with HIV and for screening for HIV in patients with tuberculosis and their contacts.Isoniazid Preventive Therapy Completion in the Era of Differentiated HIV Care.Cheaper antiretrovirals to treat AIDS in South Africa. They are at their most cost effective in preventing mother to child transmission.In vitro studies on the toxicity of isoniazid in different cell lines.The sound of one hand clapping: tuberculosis and antiretroviral therapy in Africa.Designing and Evaluating Interventions to Halt the Transmission of Tuberculosis.Higher set point plasma viral load and more-severe acute HIV type 1 (HIV-1) illness predict mortality among high-risk HIV-1-infected African women.Review editorial: prevention of tuberculosis in resource-poor countries with increasing access to highly active antiretroviral treatment.Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children.The white and the three-letter plague: integration of TB and HIV care in sub-Saharan Africa
P2860
Q24241052-79B78E60-458E-435B-853F-398B9247FA39Q24247409-6C9F7959-0DB6-4174-8A5E-7911C4109260Q24550678-28D8CE45-5C58-4C9F-9E32-CCBC66C5970EQ26778385-396F7C0D-6FE9-4778-B51A-A0857A89B304Q26991633-B80C56B8-CA51-461B-990E-053532BBA51FQ33813159-52033CA0-6D6D-4814-BC0F-C4037C6DA100Q33896460-9D3ACAF3-377D-41CA-A8EE-B5FF29BCB737Q33908570-A90CF1B7-3D96-4D09-B2E1-5F9FB992B546Q34094345-46EF026E-F5FD-406B-ABB7-036255A2ABEDQ34113940-A7BC3EF3-67E4-4601-AF53-4717856BCD33Q34475542-8CF00550-B838-494F-9526-CAB5F3990FEEQ34717889-FF708131-E618-474C-8454-BA2AF4B3F7F9Q35382545-E4DAA9E2-CC9E-4BA7-B799-21DC5F15D502Q35606554-CAC3E7E7-81BC-4920-BC43-1B7FFE3A77D0Q36029457-60093113-379D-416A-B7C9-512993E085CEQ36223899-309848EA-7057-4312-85E8-04594A528302Q36493894-AD1BB8FC-3DBB-419F-BF8B-3741A161442EQ37895251-164CA345-B57C-4A18-8A93-8BC94C20F343Q39198710-E82310D8-22D7-40F2-BB01-2FE25E78D3C5Q39834471-E9D52D33-9A01-49A3-B56E-AB39F2C940B6Q39922476-244E11BB-305B-4418-BB7A-4757753E7616Q40060774-227C46C0-BDE2-451C-AFC9-B90A1F278E5DQ42786564-0298FCDB-71AA-488D-9397-CD413F9C6D83Q44699895-B85259F7-B16F-4D67-9F38-C7CC1A4C0E24Q46351467-59BC663E-A8F9-4FA2-B608-186C736EA145Q46410213-D9006F4D-D9E0-4DE0-9391-2AF5A2D6EBACQ46695815-C4CDB0B8-77A9-4436-B990-3F560FAAC52FQ46854958-DAFB8326-7C03-4D8D-8B43-D76477B6E991Q53641549-5DC601CA-5D71-42A5-ABBD-B0E44C141708Q55546966-A49F1469-D902-4515-8CC2-AC21C3D898DD
P2860
Effect of preventive treatment for tuberculosis in adults infected with HIV: systematic review of randomised placebo controlled trials
description
1998 nî lūn-bûn
@nan
1998 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Effect of preventive treatment ...... ised placebo controlled trials
@ast
Effect of preventive treatment ...... ised placebo controlled trials
@en
type
label
Effect of preventive treatment ...... ised placebo controlled trials
@ast
Effect of preventive treatment ...... ised placebo controlled trials
@en
prefLabel
Effect of preventive treatment ...... ised placebo controlled trials
@ast
Effect of preventive treatment ...... ised placebo controlled trials
@en
P2860
P356
P1433
P1476
Effect of preventive treatment ...... ised placebo controlled trials
@en
P2093
D Wilkinson
S B Squire
P2860
P304
P356
10.1136/BMJ.317.7159.625
P407
P50
P577
1998-09-01T00:00:00Z